Outcomes

New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.

By |2023-03-02T15:52:24-04:00March 1st, 2023|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)

This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.

By |2025-06-26T09:07:24-04:00January 2nd, 2023|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Still Not Enough Data on the Reproductive Safety of Oxcarbazepine (Trileptal)

Essential Reads: What You Need to Know About Bioidentical Hormone Therapy for Menopausal Symptoms

While many peri- and post-menopausal women request bioidentical hormones, there is no data to suggest that bioidential hormones are safer or more effective than FDA-approved hormone replacement therapies.

By |2022-12-06T12:29:59-04:00November 8th, 2022|Anti-Epileptic Drugs, Essential Reads, Menopausal Symptoms, Outcomes, Risk of Malformations|Comments Off on Essential Reads: What You Need to Know About Bioidentical Hormone Therapy for Menopausal Symptoms

Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects

Despite the unequivocal benefits of folic acid supplementation and recommendations urging all women of reproductive age to take folic acid supplements, preconceptual use of folic acid has not increased substantially.

By |2022-08-29T14:34:36-04:00August 24th, 2022|Alternative & Complementary, Essential Reads, Outcomes, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects

Essential Reads: The Negative Impact of Prenatal Opioid Use on Fertility, Pregnancy, Neonatal Outcomes and Long-Term Developmental Outcomes

Prenatal opioid use is associated with increased maternal and infant mortality, prematurity, and poor neonatal outcomes.

By |2022-06-22T13:47:19-04:00June 22nd, 2022|Essential Reads, Opioids, Outcomes, Perinatal Substance Use|Comments Off on Essential Reads: The Negative Impact of Prenatal Opioid Use on Fertility, Pregnancy, Neonatal Outcomes and Long-Term Developmental Outcomes

Accumulating Data on the Reproductive Safety of Second-Generation Antipsychotics, But Still Not Enough

In a cohort of 351 children exposed to second generation antipsychotic during pregnancy, the risk of major congenital malformations did not differ from a comparison group of non-exposed children.

By |2022-12-08T18:32:09-04:00June 21st, 2022|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Accumulating Data on the Reproductive Safety of Second-Generation Antipsychotics, But Still Not Enough

Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy

Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.

By |2024-04-14T16:15:33-04:00April 5th, 2022|Antipsychotic Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Go to Top